Clinical trials keep the treatment pipeline for old and new diseases going but can technology, specifically data management, significantly improve outcomes, spend as well as time-to-market?
Clinical trials keep the treatment pipeline for old and new diseases going but can technology, specifically data management, significantly improve outcomes, spend as well as time-to-market?